Skip to content

Clinical trials

Phase 1 Breast Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Country / region: Japan Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20081
20092
20102
20111
20142
20151
20174
20182
20193
20205
20211
20224
20231
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting7
Recruiting7
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Novartis Pharmaceuticals4
AbbVie3
AstraZeneca3
Eisai Co., Ltd.3
GlaxoSmithKline3
Pfizer2
Alterome Therapeutics, Inc.1
Astellas Pharma Global Development, Inc.1
BeOne Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms39
Neoplasms10
Ovarian Neoplasms8
Endometrial Neoplasms7
Neoplasm Metastasis6
Stomach Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Lung Neoplasms4
Esophageal Neoplasms3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.